Accordingly, it can be concluded that the proto-oncoprotein c-Jun, as a key regulator, is effectively activated under HG conditions and suppressed under ferroptosis conditions, suggesting that c-Jun is a valuable target for HCC treatment. Here, JUN is linked to hepatocellular carcinoma.